Arkolith/Insider Trading/CDTX/Form 4

Stein Jeffrey

President & CEO, DirectorCidara Therapeutics, Inc. (CDTX) · full profile →Form 4 · filed Jan 7, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
14
3 non-derivative · 11 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 7, 2026Disposed to issuer(D)6K$221.50$1.3M0
Jan 7, 2026Disposed to issuer(D)67K$221.50$15.0M0
Jan 7, 2026Disposed to issuer(D)2K$221.50$527K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 7, 2026Disposed to issuer(D)16K——0
Jan 7, 2026Disposed to issuer(D)27K——0
Jan 7, 2026Disposed to issuer(D)52K——0
Jan 7, 2026Disposed to issuer(D)561K——0
Jan 7, 2026Disposed to issuer(D)275K——0
Jan 7, 2026Disposed to issuer(D)8K——0
Jan 7, 2026Disposed to issuer(D)11K——0
Jan 7, 2026Disposed to issuer(D)12K——0
Jan 7, 2026Disposed to issuer(D)13K——0
Jan 7, 2026Disposed to issuer(D)16K——0
Jan 7, 2026Disposed to issuer(D)26K——0

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001478831-26-000005) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML